Skip to main content
SpringerLink
Log in

Do uterotonic drugs increase risk of abruptio placentae and eclampsia?

  • Maternal-Fetal Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

To determine whether the use of uterotonics, including oxytocin and prostaglandins, increases the risk of abruptio placentae and eclampsia.

Materials and methods

A retrospective analysis was conducted among 260,174 Japanese women at term. Demographic characteristics were studied as possible candidates for risk factors of abruptio placentae and eclampsia using multivariate logistic regression analyses.

Results

A total of 1,058 (0.41 %) and 147 (0.06 %) women developed abruptio placentae and eclampsia, respectively. Abruptio placentae and eclampsia occurred in 177 (0.29 %) and 42 (0.07 %) of the 61,857 women treated with uterotonics, respectively. Multivariate regression analyses indicated that uterotonics did not increase risk of developing either abruptio placentae or eclampsia. Primiparity [odds ratio (95 % confidence interval) 1.41 (1.24–1.60)], age ≥35 years [1.17 (1.03–1.33)], and presence of hypertension [2.42 (1.93–3.03)] were significant independent risk factors for abruptio placentae, while advancing gestation [0.67 (0.63–0.71)] decreased risk of abruptio placentae. Primiparity [odds ratio (95 % confidence interval) 4.06 (2.49–6.63)], age <20 years [2.44 (1.07–5.58)], presence of hypertension [28.7 (20.5–40.1)], and advancing gestation [1.28 (1.11–1.47)] were significant independent risk factors for eclampsia.

Conclusion

The use of uterotonics did not increase the risk of abruptio placentae and eclampsia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pharmaceutical and Food Safety Bureau, Japanese Ministry of Labour, Health and Welfare (2010) Concerning revision of package insert (file number 0601-1)

  2. Knight M, Tuffnell D, Brocklehurst P, Spark P, Kurinczuk JJ, UK Obstetric Surveillance System (2010) Incidence and risk factors for amniotic-fluid embolism. Obstet Gynecol 115:910–917

    Article  PubMed  Google Scholar 

  3. Roberts CL, Algert CS, Knight M, Morris JM (2010) Amniotic fluid embolism in an Australian population-based cohort. BJOG 117:1417–1421

    Article  CAS  PubMed  Google Scholar 

  4. Knight M, Berg C, Brocklehurst P, Kramer M, Lewis G, Oats J, Roberts CL, Spong C, Sullivan E, van Roosmalen J, Zwart J (2012) Amniotic fluid embolism incidence, risk factors and outcomes: a review and recommendations. BMC Pregnancy Childbirth. doi:10.1186/1471-2393-12-7

    PubMed Central  PubMed  Google Scholar 

  5. Yamada T, Yamada T, Morikawa M, Takeda M, Akaishi R, Nishida R, Araki N, Koyama T, Minakami H (2011) Do uterotrophic drugs increase the risk of fatal hemorrhagic brain stroke? J Perinat Med 39:23–26

    Article  PubMed  Google Scholar 

  6. Fontenot MT, Lewis DF, Barton CB, Jones EM, Moore JA, Evans AT (2005) Abruptio placentae associated with misoprostol use in women with preeclampsia. J Reprod Med 50:653–658

    CAS  PubMed  Google Scholar 

  7. Martinez de Tejada B, Martillotti G, Lapaire O, Hoesli I, Irion O (2010) The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: comparing misoprostol versus dinoprostone. J Matern Fetal Neonatal Med 23:988–993

    Article  CAS  PubMed  Google Scholar 

  8. Minakami H, Hiramatsu Y, Koresawa M et al (2011) Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2011 edition. J Obstet Gynaecol Res 37:1174–1197

    Article  PubMed  Google Scholar 

  9. Morikawa M, Cho K, Yamada T, Yamada T, Sato S, Minakami H (2012) Risk factors for eclampsia in Japan between 2005 and 2009. Int J Gynaecol Obstet 117:66–68

    Article  PubMed  Google Scholar 

  10. Matsuda Y, Hayashi K, Shiozaki A, Kawamichi Y, Sato S, Saito S (2011) Comparison of risk factors for placental abruption and placenta previa: case–cohort study. J Obstet Gynaecol Res 37:538–556

    Article  PubMed  Google Scholar 

  11. Koopmans CM, Bijlenga D, Groen H, Vijgen SM, Aarnoudse JG, Bekedam DJ, van den Berg PP, de Boer K, Burggraaff JM, Bloemenkamp KW, Drogtrop AP, Franx A, de Groot CJ, Huisjes AJ, Kwee A, van Loon AJ, Lub A, Papatsonis DN, van der Post JA, Roumen FJ, Scheepers HC, Willekes C, Mol BW, van Pampus MG; HYPITAT study group (2009) Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 374:979–988

    Google Scholar 

  12. Minakami H, Kubo T, Takeda S, Kawabata M, Kobayashi T, Nakabayashi M (2009) Placental abruption, HELLP syndrome, and eclampsia in Japan. Nippon Sanka-Fujinka Gakkai Zasshi 61:1559–1567 (in Japanese)

    Google Scholar 

  13. Sheiner E, Shoham-Vardi I, Hadar A, Hallak M, Hackmon R, Mazor M (2002) Incidence, obstetric risk factors and pregnancy outcome of preterm placental abruption: a retrospective analysis. J Matern Fetal Neonatal Med 11:34–39

    Article  CAS  PubMed  Google Scholar 

  14. Sheiner E, Shoham-Vardi I, Hallak M, Hadar A, Gortzak-Uzan L, Katz M, Mazor M (2003) Placental abruption in term pregnancies: clinical significance and obstetric risk factors. J Matern Fetal Neonatal Med 13:45–49

    Article  CAS  PubMed  Google Scholar 

  15. Kullberg G, Lindeberg S, Hanson U (2002) Eclampsia in Sweden. Hypertens Pregnancy 21:13–21

    Article  PubMed  Google Scholar 

  16. Douglas KA, Redman CWG (1994) Eclampsia in the United Kingdom. BMJ 309:1395–1400

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Knight M; UKOSS (2007) Eclampsia in the United Kingdom 2005. BJOG 114:1072–1078

  18. van der Tuuk K, Koopmans C, Groen H, Mol BW, van Pampus MG; HYPITAT study group (2011) Impact of the HYPITAT trial on doctors’ behaviour and prevalence of eclampsia in the Netherlands. BJOG 118:1658–1660

    Google Scholar 

  19. Jozwiak M, Oude Rengerink K, Benthem M, van Beek E, Dijksterhuis MG, de Graaf IM, van Huizen ME, Oudijk MA, Papatsonis DN, Perquin DA, Porath M, van der Post JA, Rijnders RJ, Scheepers HC, Spaanderman ME, van Pampus MG, de Leeuw JW, Mol BW, Bloemenkamp KW; PROBAAT Study Group (2011) Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trial. Lancet 378:2095–2103

Download references

Conflict of interest

All the authors declare that they have no financial relationships with a biotechnology manufacturer, pharmaceutical company, or other commercial entity that has an interest in the subject matter or the materials discussed in the manuscript.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, Kita-ku N15 W7, Sapporo, 060-8638, Japan

    Mamoru Morikawa, Kazutoshi Cho, Takahiro Yamada, Takashi Yamada & Hisanori Minakami

  2. Maternal and Perinatal Care Center, Oita Prefectural Hospital, Bunyo 476, Oita, 870-8511, Japan

    Shoji Sato

Authors
  1. Mamoru Morikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazutoshi Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takahiro Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shoji Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hisanori Minakami
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mamoru Morikawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morikawa, M., Cho, K., Yamada, T. et al. Do uterotonic drugs increase risk of abruptio placentae and eclampsia?. Arch Gynecol Obstet 289, 987–991 (2014). https://doi.org/10.1007/s00404-013-3101-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-013-3101-8

Keywords

Search

Navigation